XML 42 R30.htm IDEA: XBRL DOCUMENT v3.19.2
Derivative Instruments (Tables)
6 Months Ended
Jun. 30, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Derivative Instruments Reported in Financial Position The detail of derivative instruments is shown below (in thousands, except number of instruments):
 
Derivatives Not Designated
as Hedging Instruments
 
Location in the Consolidated
Statements of Financial Position
 
June 30, 2019
 
December 31, 2018
 
 
Number of
Instruments
 
Notional
Amounts
 
Estimated
Fair Value
 
Number of
Instruments
 
Notional
Amounts
 
Estimated
Fair Value
 
 
Equity-indexed options
 
Other invested assets
 
484

 
$
2,498,744

 
$
231,044

 
493

 
$
2,391,000

 
$
148,006

 
Equity-indexed embedded derivative
 
Policyholders’ account balances
 
96,014

 
2,455,001

 
695,676

 
90,440

 
2,327,769

 
596,075


Schedule of Derivative Instruments Reported in Statements of Operations
Derivatives Not Designated
as Hedging Instruments
 
Location in the Consolidated
Statements of Operations
 
Gains (Losses) Recognized in Income on Derivatives
 
Three months ended June 30,
 
Six months ended June 30,
 
2019
 
2018
 
2019
 
2018
Equity-indexed options
 
Net investment income
 
$
23,125

 
$
21,778

 
$
89,610

 
$
7,633

Equity-indexed embedded derivative
 
Interest credited to policyholders’
 account balances
 
(36,255
)
 
(17,599
)
 
(94,411
)
 
(4,163
)

Schedule of Information Regarding Company's Exposure to Credit Loss on the Options Holds
Information regarding the Company’s exposure to credit loss on the options it holds is presented below (in thousands):
 
 
 
 
June 30, 2019
Counterparty
 
Moody/S&P
Rating
 
Options Fair
Value
 
Collateral  Held in Cash
 
Collateral Held in Invested Assets
 
Total
Collateral Held
 
Collateral Amounts used to Offset Exposure
 
Excess Collateral
 
Exposure Net of Collateral
Barclays
 
Baa3/BBB
 
$
53,790

 
$
25,393

 
$
28,000

 
$
53,393

 
$
53,393

 
$

 
$
397

Credit Suisse
 
Baa2/BBB+
 
1,223

 
1,150

 

 
1,150

 
1,150

 

 
73

Goldman-Sachs
 
A3/BBB+
 
909

 
670

 

 
670

 
670

 

 
239

ING
 
Baa1/A-
 
28,382

 
12,830

 
16,000

 
28,830

 
28,382

 
448

 

Morgan Stanley
 
A3/BBB+
 
26,538

 
17,516

 
9,000

 
26,516

 
26,516

 

 
22

NATIXIS*
 
A1/A+
 
38,289

 
38,700

 

 
38,700

 
38,289

 
411

 

SunTrust
 
Baa1/BBB+
 
48,347

 
32,350

 
17,000

 
49,350

 
48,320

 
1,030

 
27

Wells Fargo
 
A2/A-
 
33,566

 
18,550

 
15,000

 
33,550

 
33,313

 
237

 
253

       Total
 
 
 
$
231,044

 
$
147,159

 
$
85,000

 
$
232,159

 
$
230,033

 
$
2,126

 
$
1,011

 
 
 
 
December 31, 2018
Counterparty
 
Moody/S&P
Rating
 
Options Fair
Value
 
Collateral  Held in Cash
 
Collateral Held in Invested Assets
 
Total
Collateral Held
 
Collateral Amounts used to Offset Exposure
 
Excess Collateral
 
Exposure Net of Collateral
Barclays
 
Baa3/BBB
 
$
38,905

 
$
11,063

 
$
28,041

 
$
39,104

 
$
38,905

 
$
199

 
$

Goldman-Sachs
 
A3/BBB+
 
615

 
670

 

 
670

 
615

 
55

 

ING
 
Baa1/A-
 
24,183

 
7,960

 
16,023

 
23,983

 
23,983

 

 
200

Morgan Stanley
 
A3/BBB+
 
11,649

 
2,046

 
9,013

 
11,059

 
11,059

 

 
590

NATIXIS*
 
A1/A+
 
26,786

 
27,610

 

 
27,610

 
26,786

 
824

 

SunTrust
 
Baa1/BBB+
 
23,488

 
6,520

 
17,025

 
23,545

 
23,464

 
81

 
24

Wells Fargo
 
A2/A-
 
22,380

 
7,030

 
15,022

 
22,052

 
22,052

 

 
328

       Total
 
 
 
$
148,006

 
$
62,899

 
$
85,124

 
$
148,023

 
$
146,864

 
$
1,159

 
$
1,142

*
Includes collateral restrictions.